The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection
Open accessAbstract
The SARS-CoV-2 Omicron variant evades most currently approved neutralizing antibodies (nAbs) and caused drastic decrease of plasma neutralizing activity elicited by vaccination or prior infection, urging the need for the development of pan-variant antivirals. Breakthrough infection induces a hybrid immunological response with potentially broad, potent and durable protection against variants, therefore, convalescent plasma from breakthrough infection may provide a broadened repertoire for identifying elite nAbs. We performed single-cell RNA sequencing (scRNA-seq) and BCR sequencing (scBCR-seq) of B cells from BA.1 breakthrough-infected patients who received 2 or 3 previous doses of inactivated vaccine. Elite nAbs, mainly derived from the IGHV2–5 and IGHV3-66/53 germlines, showed potent neutralizing activity across Wuhan-Hu-1, Delta, Omicron sublineages BA.1 and BA.2 at picomolar NT 50 values. Cryo-EM analysis revealed diverse modes of spike recognition and guides the design of cocktail therapy. A single injection of paired antibodies cocktail provided potent protection in the K18-hACE2 transgenic female mouse model of SARS-CoV-2 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the realm of infectious diseases, the technologies shed light on host-pathogen dynamics, immune responses, and advanced therapeutic strategies, especially in COVID-19 [145, 146, 219–223].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [145]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Combined with scRNA-seq, scBCR-seq was applied for producing cell atlas [144], identifying different neutralizing antibodies [145], conducting vaccine studies [146], etc., and proved invaluable in studies investigating the dynamics of the immune system.”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [145]
The cited source says what the claim attributes to it.
In the citing paper
“A study focused on the breakthrough infection and pan-variant antivirals, and they successfully identified elite neutralizing antibodies (nAbs) repertoire using scRNA/BCR-seq of B cells, which showed strong neutralizing activity targeting numerous variants [145].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828 · cited 2×
“Theatomicmodelsof thecomplexesweregeneratedby fi rst fi ttingthe chains of the SARS-CoV-2 S trimer and Fabs (PDB ID: 7XOD) 49 into the cryo-EM maps using UCSF Chimera 50 .”
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915 · cited 2×
“Fitted models were then manually rebuilt using Coot 51 according to the protein sequences and map density and real-space re fi ned with secondary structure and geometry restraints against the map using Phenix 52 .”
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716 · cited 3×
“Fitted models were then manually rebuilt using Coot 51 according to the protein sequences and map density and real-space re fi ned with secondary structure and geometry restraints against the map using Phenix 52 .”
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115 · cited 1×
“Models were analyzed using MolProbity 53 .”
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
Punjani, A., Rubinstein, J. L., Fleet, D. J., & Brubaker, M. A. (2017) · Nature Methods · doi:10.1038/nmeth.4169 · Cited by 11,626
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Automated electron microscope tomography using robust prediction of specimen movements
Mastronarde, D. N. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.07.007 · Cited by 5,336
Scrublet: computational identification of cell doublets in single-cell transcriptomic data
Wolock, S. L., Lopez, R., & Klein, A. M. (2019) · Cell Systems · doi:10.1016/j.cels.2018.11.005 · Cited by 2,758
Research works printed but not linked: 1
- Cele, S. et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization. Nature 602, 654–656 (2022). · doi:10.1038/s41586-021-04387-1 · Paper page
Cited by
Single-cell sequencing to multi-omics: technologies and applications
Wu, X., Yang, X., Dai, Y., Zhao, Z., Zhu, J., Guo, H., & Yang, R. (2024) · Biomarker Research · doi:10.1186/s40364-024-00643-4 · Cited by 222
“In the realm of infectious diseases, the technologies shed light on host-pathogen dynamics, immune responses, and advanced therapeutic strategies, especially in COVID-19 [145, 146, 219–223].”
BackgroundMethodInfluentialSelf-citationLu, Y., Yang, Q., Ran, T., Zhang, G., Li, W., Zhou, P., Tang, J., Dai, M., Zhong, J., Chen, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54462-0 · Cited by 49
“In this assay, the cytopathic effect (CPE) of SARS-CoV-2-infected Vero E6 cells with or withouttreatmentby thecompoundswasassessedusing CeligoImage Cytometer 45 .”
Self-citationStructural Immunology of SARS ‐ CoV ‐2
Yuan, M., & Wilson, I. A. (2024) · Immunological Reviews · doi:10.1111/imr.13431 · Cited by 29
Yang, P., Wu, X., Shang, H., Sun, Z., Wang, Z., Song, Z., Yuan, H., Dèng, F., Shěn, S., Guo, Y., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012550 · Cited by 19
Self-citationLiao, Y., Ma, H., Wang, Z., Wang, S., He, Y., Chang, Y., Zong, H., Tang, H., Wang, L., Ke, Y., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406659122 · Cited by 12
Self-citation
Metadata
- Authors
- Guo, Y., Zhang, G., Yang, Q., Xie, X., Lu, Y., Cheng, X., Wang, H., Liang, J., Tang, J., Gao, Y., Shang, H., Dai, J., Shi, Y., Zhou, J., Zhou, J., Guo, H., Yang, H., Qi, J., Liu, L., Ma, S., Zhang, B., Huo, Q., Xie, Y., Wu, J., Dong, F., Zhang, S., Lou, Z., Gao, Y., Song, Z., Wang, W., Sun, Z., Yang, X., Xiong, D., Liu, F., Chen, X., Zhu, P., Wang, X., Cheng, T., & Rao, Z.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Nankai University (CN)
- Guangzhou Laboratory (CN)
- ShanghaiTech University (CN)
- Tianjin haihe hospital (CN)
- Corresponding author
- Guo, Yu
- Yang, Qi
- Yang, Xiaoming
- Xiong, Dongsheng
- Liu, Fengjiang
- Chen, Xinwen
- Zhu, Ping
- Wang, Ximo
- Cheng, Tao
- Rao, Zihe
- ORCID
- Guo, Yu
- Zhang, Guangshun
- Yang, Qi
- Xie, Xiaowei
- Lu, Yang
- Wang, Hui
- Liang, Jingxi
- Tang, Jielin
- Gao, Yuxin
- Shang, Hang
- Shi, Yongxia
- Zhou, Jiaxi
- Zhou, Jun
- Guo, Hangtian
- Yang, Haitao
- Qi, Jianwei
- Liu, Lijun
- Ma, Shihui
- Zhang, Biao
- Xie, Yi
- Wu, Junping
- Zhang, Song
- Lou, Zhiyong
- Gao, Yan
- Wang, Wenming
- Sun, Zixian
- Yang, Xiaoming
- Xiong, Dongsheng
- Liu, Fengjiang
- Chen, Xinwen
- Zhu, Ping
- Wang, Ximo
- Cheng, Tao
- Rao, Zihe
- Venue
- Nature Communications
- Published
- 2023-06-15
- Volume
- 14
- Issue
- 1
- Pages
- 3537-3537
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC10267556
- OpenAlex
- W4380681008
- Cited by
- 28
- References
- 54
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 9 · 2023: 1
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81890990, 81730006, 32271256)
- ShanghaiTech University
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Keywords
- Omicron variant, neutralizing antibodies, breakthrough infection, convalescent plasma, BA.1, BA.2, B cell receptor repertoire, vaccine escape, single-cell RNA sequencing
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Serotherapy, Breakthrough Infections, Animals, Antibodies, Viral, Female, Mice, Transgenic, Mice, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection. https://app.cochat.ai/papers/10.1038/s41467-023-39267-x
- The paper
- Guo, Y., Zhang, G., Yang, Q., Xie, X., Lu, Y., Cheng, X., Wang, H., Liang, J., Tang, J., Gao, Y., Shang, H., Dai, J., Shi, Y., Zhou, J., Zhou, J., Guo, H., Yang, H., Qi, J., Liu, L., . . . Rao, Z. (2023). Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection. Nature Communications. https://doi.org/10.1038/s41467-023-39267-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.